Cambrex Expands Generic API Research and Development Capabilities at Milan, Italy Site
EAST RUTHERFORD, N.J., June 12, 2018 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE:CBM), the leading manufacturer of small molecule innovator and generic Active Pharmaceutical Ingredients (APIs), today announced that it will expand research and development …